Treatment of TRPV3 mutation-associated Olmsted syndrome with erlotinib

Kathleen E Spitz; Lena Chu; Leslie P Lawley

doi:10.1016/j.jdcr.2022.05.029

Treatment of TRPV3 mutation-associated Olmsted syndrome with erlotinib

JAAD Case Rep. 2022 Jun 7:25:83-85. doi: 10.1016/j.jdcr.2022.05.029. eCollection 2022 Jul.

Authors

Kathleen E Spitz¹, Lena Chu¹, Leslie P Lawley¹

Affiliation

¹ Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.

No abstract available

Keywords: EGFR, epidermal growth factor receptor; OS, Olmsted syndrome; Olmsted syndrome; PPK, palmoplantar keratoderma; TRPV3, transient receptor potential vanilloid-3; erlotinib.

Publication types

Case Reports